This research did not find correlation between sarcopenia and acute liver failure.
Post
Categoria: Hepatologia
Post
Non-invasive method of monitoring intracranial pressure for the evaluation of hepatic encephalopathy
New endoscopic features could improve better H.Pylori’s diagnostics and give more support to pathologists.
Post
Liver health is overlooked by alcohol drinkers in Brazil
O artigo conclui que a avaliação da saúde hepática no Brasil não abrange a maioria da população
Post
Non-selective beta-blockers in cirrhotic patients with refractory ascites: where are we?
O estudo analisa criticamente o uso de betabloqueadores em pacientes com ascite refratária
Post
Association between anxiety and depression in metabolic dysfunction-associated steatotic liver disease (MASLD)
The impression that anxiety or depression may be associated with hepatic steatosis is not confirmed in this study.
Post
Ten-year outcomes of TIPS for Budd-Chiari syndrome: systematic review and meta-analysis
Importante revisão histórica do TIPS como alternativa de tratamento da Síndrome de Budd-Chiari.
Post
Ten-year outcomes of TIPS for Budd-Chiari syndrome: systematic review and meta-analysis
The application of TIPS has become an important step in the control of portal hypertension. This review confirms its usefulness.
Post
Diagnostic accuracy of the non-invasive markers NFLS, NI-NASH-DS, and FIB-4 for assessment of different aspects of non-alcoholic fatty liver disease in individuals with obesity: cross-sectional study
The use of these scores in clinical practice has the potential to predict the risk of progression of a common disease through simple, non-invasive, low-cost, and widely available assessments.
Post
Non-alcoholic fatty liver disease and extra-hepatic cancer: a narrative review
Once again, it is reinforced that the conditions for carcinogenesis and the development of NAFLD are very close, if not the same.
Post
Spontaneous regression of hepatocellular carcinoma: focusing in the associated risk factors
This rare condition is studied in more than 400 patients with hepatocellular carcinoma.
